These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8523070)

  • 21. Case of the day. Mixed oligodendroglioma.
    Vezina JL; Tampieri D
    Radiographics; 1990 Mar; 10(2):364-5. PubMed ID: 2326515
    [No Abstract]   [Full Text] [Related]  

  • 22. Oligodendrogliomas.
    Reiche W; Grunwald I; Hermann K; Deinzer M; Reith W
    Acta Radiol; 2002 Sep; 43(5):474-82. PubMed ID: 12423457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging.
    Rijpkema M; Schuuring J; van der Meulen Y; van der Graaf M; Bernsen H; Boerman R; van der Kogel A; Heerschap A
    NMR Biomed; 2003 Feb; 16(1):12-8. PubMed ID: 12577293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
    Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
    J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary oligodendroglioma of the lateral ventricle.
    Lee KS; Kelly DL
    South Med J; 1990 Feb; 83(2):254-5. PubMed ID: 2406943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on oligodendroglial neoplasms.
    Baehring JM
    Curr Opin Neurol; 2005 Dec; 18(6):639-44. PubMed ID: 16280674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance and prospects of study on molecular alterations in oligodendrogliomas].
    Gresner SM; Liberski PP
    Neurol Neurochir Pol; 2007; 41(4):333-9. PubMed ID: 17874342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligodendroglial tumors.
    Chowdhary S; Chamberlain MC
    Expert Rev Neurother; 2006 Apr; 6(4):519-32. PubMed ID: 16623651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
    Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
    Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligodendrogliomas of the fourth ventricle: report of two cases.
    Greenwood J; Otenasek FJ; Yelin FS
    J Neurol Neurosurg Psychiatry; 1969 Jun; 32(3):226-9. PubMed ID: 5306178
    [No Abstract]   [Full Text] [Related]  

  • 31. Extracranial relapse of an anaplastic oligodendroglioma in an adolescent: case report and review of the literature.
    Bruggers C; White K; Zhou H; Chen Z
    J Pediatr Hematol Oncol; 2007 May; 29(5):319-22. PubMed ID: 17483710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multifocal oligodendroglioma. A case report].
    Szymaś J; Liebert W
    Patol Pol; 1989; 40(1):129-34. PubMed ID: 2797912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of tumor-enhancement and angiogenesis in oligodendroglioma.
    Vaquero J; Zurita M; Morales C; Coca S
    Acta Neurol Scand; 2002 Jul; 106(1):19-23. PubMed ID: 12067323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradoxic appearance of calcification on MRI.
    Kuzma BB; Goodman JM
    Surg Neurol; 1996 Nov; 46(5):513-4. PubMed ID: 8874556
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular genetics, imaging and treatment of oligodendroglial tumours.
    Jenkinson MD; Walker C; Brodbelt AR; Wilkins S; Husband D; Haylock B
    Acta Neurochir (Wien); 2010 Nov; 152(11):1815-25. PubMed ID: 20811757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligodendroglioma with a twenty-two year history. Clinicopathological case report.
    Aebi M; Kraus-Ruppert R
    J Neurol; 1978 Oct; 219(2):139-44. PubMed ID: 81292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of low-grade oligodendroglioma and mixed glioma.
    Olson JD; Riedel E; DeAngelis LM
    Neurology; 2000 Apr; 54(7):1442-8. PubMed ID: 10751254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
    Cairncross G; Macdonald D; Ludwin S; Lee D; Cascino T; Buckner J; Fulton D; Dropcho E; Stewart D; Schold C
    J Clin Oncol; 1994 Oct; 12(10):2013-21. PubMed ID: 7931469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and pathologic correlations between "pure" and "transitional" oligodendrogliomas].
    Hlavka V; Jelicić I; Miklić P
    Acta Med Iugosl; 1988; 42(1):31-43. PubMed ID: 3364211
    [No Abstract]   [Full Text] [Related]  

  • 40. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
    Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
    Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.